Previous Close | 55.72 |
Open | 56.00 |
Bid | 56.59 x 900 |
Ask | 57.86 x 900 |
Day's Range | 55.79 - 56.81 |
52 Week Range | 50.92 - 81.78 |
Volume | |
Avg. Volume | 1,465,433 |
Market Cap | 5.683B |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | 28.75 |
EPS (TTM) | 1.97 |
Earnings Date | May 08, 2023 - May 12, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 66.58 |
Subscribe to Yahoo Finance Plus to view Fair Value for GMED
In this Motley Fool Money podcast, Motley Fool senior analysts Emily Flippen and Ron Gross join host Chris Hill to discuss: Fear of a recession vs. fear of banking contagion. Whether social media giants like Meta Platforms and Snap stand to benefit from the drama around TikTok.
The NuVasive acquisition aims to outpace market growth by combining Globus Medical's (GMED) engineering and NuVasive's relations, education and training.
According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.